Authors: Malabarba, MG Milia, E Faretta, M Zamponi, R Pelicci, PG Di Fiore, PP

Citation: Mg. Malabarba et al., A repertoire library that allows the selection of synthetic SH2s with altered binding specificities, ONCOGENE, 20(37), 2001, pp. 5186-5194

Authors: Sironi, L Melixetian, M Faretta, M Prosperini, E Helin, K Musacchio, A

Citation: L. Sironi et al., Mad2 binding to Mad1 and Cdc20, rather than oligomerization, is required for spindle checkpoint, EMBO J, 20(22), 2001, pp. 6371-6382

Authors: Faretta, M Di Croce, L Pelicci, PG

Citation: M. Faretta et al., Effects of the acute myeloid leukemia-associated fusion proteins on nuclear architecture, SEM HEMATOL, 38(1), 2001, pp. 42-53

Authors: Cappella, P Tomasoni, D Faretta, M Lupi, M Montalenti, F Viale, F Banzato, F D'Incalci, M Ubezio, P

Citation: P. Cappella et al., Cell cycle effects of gemcitabine, INT J CANC, 93(3), 2001, pp. 401-408

Authors: Erba, E Bergamaschi, D Ronzoni, S Faretta, M Taverna, S Bonfanti, M Catapano, CV Faircloth, G Jimeno, J D'Incalci, M

Citation: E. Erba et al., Mode of action of thiocoraline, a natural marine compound with anti-tumouractivity, BR J CANC, 80(7), 1999, pp. 971-980

Authors: Bergamaschi, D Ronzoni, S Taverna, S Faretta, M De Feudis, P Faircloth, G Jimeno, J Erba, E D'Incalci, M

Citation: D. Bergamaschi et al., Cell cycle perturbations and apoptosis induced by isohomohalichondrin B (IHB), a natural marine compound, BR J CANC, 79(2), 1999, pp. 267-277